Contact Person : Varsha Luthra; Last Date for the submission of abstract : 23/07/2010; Description : The ubiquitin story continues to grow as more companies exploit this critical regulatory pathway for the discovery and development of therapeutics. Members of the academic, pharmaceutical, biotech and business communities to exchange ideas.